MXCT vs NDSN · rev $38.6M vs P/E 31, rev $2.69B
MaxCyte Inc (MXCT) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported NDSN revenue for 2024-10-31 was $2.69B. Net income was $467.3M. Revenue was up 2.3% from 2023-10-31 to 2024-10-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
MXCT currently screens at market cap $124.3M. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the MXCT and NDSN stock pages for the full models.
Not investment advice.